Two statements from the European Task Force on Atopic Dermatitis (ETFAD) on Corona virus (Covid-19) and Atopic Dermatitis Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts ➜ J Eur Acad Dermatol Venereol, 2021 Mar 22. doi: 10.1111/jdv.17237. Online […]
Read More
Dear Colleagues, Dear Friends, Already 250 abstracts submitted to the hybrid Seoul meeting! I am happy to announce that we have open, in conjunction with the localorganizing committee, the possibility to submit late-breaking abstracts until March 12. If accepted, they will be published with the other abstracts at the date of themeeting in the ActaDV. […]
Read More
Dear Colleagues, dear Friends, I am happy to announce the simultaneous launch of two competitive calls for project, the ISAD 2021 research fellowship program funded by Pfizer, and the new 2021 ISAD Grants derived from our 2019 Sub-Saharan Africa Initiative (SSAI). Our Society will provide a total 95 K€ for the two programs. It is […]
Read More
SECURE-AD is a global registry of patients with atopic dermatitis who experience a COVID-19 episode:➜ https://www.secure-derm.com/ SECURE-AD registry We encourage clinicians worldwide to report all cases of COVID-19 in their atopic eczema patients, treated with or without systemic immunomodulating medication, regardless of severity (including asymptomatic patients detected through public health screening). There are currently 238 cases reported in the SECURE-AD […]
Read More
Dear Colleagues, Dear Friends, The Hero’s Journey theme underscores the Organization of Care in Atopic Dermatitis Meeting – Atopic Dermatitis Patient Journey, now available for replay. The introductory score of Richard Strauss’ op 40 Ein Heldenleben (A Hero’s Life) was chosen as a musical symbol of the Atopic Dermatitis Patient Journey by Roberto Takaoka, who organized this event on […]
Read More
I would like to draw your attention to the recently published position paper of the ISAD/OPENED task force, with a focus on the management of itch and pain in AD. Itch is central to AD, and was designed as the cardinal symptom by Besnier in the XIXth century, at the time when AD was named […]
Read More
Live on Friday, November 6, 2020From 4 to 6 pm (CET Paris time) Dear Colleagues, The patient journey is a sequence of care events which a patient follows from the point of access into the health system, continuing towards diagnosis, care, education and prevention. The journey is cyclical in nature with never-ending interactions between patient […]
Read More
Dear Colleagues, I am currently working on a project and collating written action plans (WAPs) for eczema patients, prior to officially starting my academic dermatology (St3) post later this year. I was wondering whether any of you had come across any other than the following e-WAP. This is a project from University of Bristol Academics, […]
Read More
Lennart RÖSNER is actively involved in atopic dermatitis research for nearly 10 years. Starting as a PostDoc in the lab of Thomas Werfel in Hannover, Germany, he is now also a junior research group leader. His research projects target deep characterization and enumeration of allergen-specific T cells and regulatory T cells in order to understand […]
Read More
Dear Colleagues, Dear Friends, We are now less than 10 days from our live digital AD meeting. If you have not yet registered, please do it to receive the link to the live meeting, but also to the access to recorded talks available before the meeting. Following coverage of the impact of COVID 19 on […]
Read More